Literature DB >> 17680657

High-density transfection with HEK-293 cells allows doubling of transient titers and removes need for a priori DNA complex formation with PEI.

Gaurav Backliwal1, Markus Hildinger, Vivek Hasija, Florian M Wurm.   

Abstract

Recombinant proteins are of great commercial and scientific interest. Yet, most production methods in mammalian cells involve the time- and labor-consuming step of creating stable cell lines. Production methods based on transient gene expression are advantageous in terms of speed and versatility; yet, depending on the transfection protocol, transient transfection faces some bottlenecks such as a priori complex formation, limitations in terms of transfection and production media used and the need for medium exchange prior to and/or after transfection. Published protocols for transfection of suspension-adapted HEK-293 cells with polyethyleneimine have shown great promise in overcoming some of these bottlenecks, but still require a priori complex formation for optimal yields and limit the choice of transfection and production media. Here, we report successful in situ transfection of suspension-adapted HEK-293 cells with 25-kDa linear polyethyleneimine at densities up to 20 x 10(6) cells/mL in complex media followed by production at lower cell densities (1 x 10(6) cells/mL). After concentrating cells to such high densities, transfection of HEK-293 cells becomes possible in most commonly used media and is not restricted to a specific medium. Furthermore, there is no need to make transfection complexes a priori, a step that prevents inline sterile filtration of the DNA bulk for transfection, an important consideration when scaling processes up to 100 or 1,000 L. Finally, transfecting HEK-293 cells at high density in complex media is superior to existing transfection protocols and doubles yields of recombinant protein obtainable by transient gene expression. (c) 2007 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17680657     DOI: 10.1002/bit.21596

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  39 in total

1.  Effect of addition of 'carrier' DNA during transient protein expression in suspension CHO culture.

Authors:  Ketaki Pradhan; Mugdha Gadgil
Journal:  Cytotechnology       Date:  2012-03-14       Impact factor: 2.058

Review 2.  Bridging the gap: facilities and technologies for development of early stage therapeutic mAb candidates.

Authors:  Trent P Munro; Stephen M Mahler; Edwin P Huang; David Y Chin; Peter P Gray
Journal:  MAbs       Date:  2011-09-01       Impact factor: 5.857

3.  Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain.

Authors:  Mischa R Müller; Kenneth Saunders; Christopher Grace; Macy Jin; Nicole Piche-Nicholas; John Steven; Ronan O'Dwyer; Leeying Wu; Lam Khetemenee; Yulia Vugmeyster; Timothy P Hickling; Lioudmila Tchistiakova; Stephane Olland; Davinder Gill; Allan Jensen; Caroline J Barelle
Journal:  MAbs       Date:  2012 Nov-Dec       Impact factor: 5.857

4.  Enhanced transient recombinant protein production in CHO cells through the co-transfection of the product gene with Bcl-xL.

Authors:  Matthew P Zustiak; Lisa Jose; Yueqing Xie; Jianwei Zhu; Michael J Betenbaugh
Journal:  Biotechnol J       Date:  2014-05-08       Impact factor: 4.677

5.  The transient expression of CHIKV VLP in large stirred tank bioreactors.

Authors:  Peifeng Chen; Jacob Demirji; Vera B Ivleva; Joe Horwitz; Richard Schwartz; Frank Arnold
Journal:  Cytotechnology       Date:  2019-09-27       Impact factor: 2.058

6.  Production of lentiviral vectors in suspension cells using low proportion of supercoiled circular plasmid DNA.

Authors:  Xin-An Lu; Ting He; Zhihai Han; Yanping Ding; Liang Zhao; Guanghua Liu; Floris De Smet; Xiaojun Huang; Danqing Chen; Feifei Qi; Xiangyu Zhao
Journal:  Cytotechnology       Date:  2020-10-29       Impact factor: 2.058

7.  Engineering, expression, purification, and characterization of stable clade A/B recombinant soluble heterotrimeric gp140 proteins.

Authors:  George Sellhorn; Zane Kraft; Zachary Caldwell; Katharine Ellingson; Christine Mineart; Michael S Seaman; David C Montefiori; Eliza Lagerquist; Leonidas Stamatatos
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

8.  Structure and stabilization of the Hendra virus F glycoprotein in its prefusion form.

Authors:  Joyce J W Wong; Reay G Paterson; Robert A Lamb; Theodore S Jardetzky
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-28       Impact factor: 11.205

9.  Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection.

Authors:  D Noah Sather; Jakob Armann; Lance K Ching; Angeliki Mavrantoni; George Sellhorn; Zachary Caldwell; Xuesong Yu; Blake Wood; Steve Self; Spyros Kalams; Leonidas Stamatatos
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

10.  High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension.

Authors:  Ganesh P Subedi; Roy W Johnson; Heather A Moniz; Kelley W Moremen; Adam Barb
Journal:  J Vis Exp       Date:  2015-12-28       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.